This study suggests that Cldn1 loss could be associated with more aggressive cancer behavior, in contrast to our results showing that Cldn1 expression correlates with poor prognosis and enhanced malignancy in pancreatic cancer cells. The gene discussed is CLDN1; the disease is familial pancreatic carcinoma.